DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dexanabinol
Dexanabinol
(12) United States Patent (10) Patent No.: US 9.435,817 B2 Benchikh Et Al
Medicinal Chemistry Endeavors Around the Phytocannabinoids
Article 22 Regulation for Restriction of Synthetic Drugs
Shlomi Cohen, Israel Manela, Eli More , Et Al. V. Pharmos Corp. , Et Al
Long Term Cerebroprotective Effects of Dexanabinol in a Model of Focal Cerebral Ischemia Gil Lavieaa,Cbaa, , Angella Teichner , Esther Shohami , Haim Ovadia , Ronen R
How Is Spice Abused? What Are the Health Effects of Spice Abuse?
(12) United States Patent (10) Patent No.: US 8.449,908 B2 Stinchcomb Et Al
Cannabinoids in Experimental Stroke: a Systematic Review
(12) Patent Application Publication (10) Pub. No.: US 2007/0104741 A1 Murty Et Al
Glutamate NMDA Receptors in Pathophysiology And
House Committee Substitute for Senate Substitute for Senate Committee Substitute for Senate Bill No
Cannabinoid CB Receptor Expression, Activation and Detection of Endogenous Ligand in Trabecular Meshwork and Ciliary Process
The Cannabinoids: an Overview
Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling
House Bill No. 2038
US 2019 / 0216870 A1 Witowski Et Al
House of Rep Daily Journal
Schedules of Controlled Substances in Conflict Herewith Are Hereby Repealed
Top View
House Bill No. 2038
Endogenous Interleukin-1 Receptor Antagonist Mediates Anti-Inflammatory and Neuroprotective Actions of Cannabinoids in Neurons and Glia
Alzheimer's Disease (AD) (THC-AD) (THC-AD)
Neuroprotection by Cannabinoids in Neurodegenerative Diseases
Ingredients Including JWH 018 and JWH 073 Ingredient
(12) Patent Application Publication (10) Pub. No.: US 2011/0195096 A1 Kindler Et Al
The Endocannabioids System and Their Implications in Various Disorders
Future of Cannabis and Cannabinoids in Therapeutics
Questions Answers
Pharmacology of Cannabinoids
Future of Cannabis and Cannabinoids in Therapeutics
21.0692.02000 House Bill No
Pr2006215.Pdf
Redalyc.Spice Drugs: Los Cannabinoides Como Nuevas
Letter Bill 1..15
Minnesota Statutes 2020, Section 152.02
Chemistry and Analysis of Phytocannabinoids and Other Cannabis Constituents
Download Ordinance
Senate Bill127
House Bill No.315 (2020)
Information for Health Care Professionals: Cannabis
Total Synthesis of Axially-Chiral Cannabinols: a New Platform for Cannabinoid-Based Drug Discovery
51St Legislature
Download Product Insert (PDF)
Cannabinoids and Brain Injury: Therapeutic Implications
Journal of the House [106Th Day
Preclinical Models of Traumatic Brain Injury: Emerging Role of Glutamate in the Pathophysiology of Depression
2011 Regular Session
Clinical Pharmacodynamics of Cannabinoids
Neuro-Oncology Advances 1 3(1), 1–9, 2021 | Doi:10.1093/Noajnl/Vdab006 | Advance Access Date 15 February 2021
Cannabinoids in Glaucoma Patients: the Never-Ending Story
CONTROLLED SUBSTANCE, DRUG, DEVICE and COSMETIC ACT - SCHEDULES of CONTROLLED SUBSTANCES Act of Jul
Cannabis Through the Looking Glass
124.204 Schedule I — Substances Included. 1
Industrial Hemp, with Penalty Provisions
Petition to Add a Qualifying Medical Condition: Ehlers Danlos Syndrome
Senate Bill No.1017 (2021)
Traumatic Brain Injury ISSUE BRIEF on TRAUMATIC BRAIN INJURY
Iowa Code § 124.204
ACMD Report on the Major Cannabinoid Agonists ACMD Advisory Council on the Misuse of Drugs
(12) United States Patent (10) Patent No.: US 6,211,230 B1 Filbert Et Al
Therapeutic Properties of Cannabinoid Drugs and Marijuana in Several Disorders: a Narrative Review
Kratom and Related Substances
Redalyc.Therapeutic Properties of Cannabinoid Drugs and Marijuana